Taylor Morrison Home Corporation (NYSE:TMHC) is a leading national homebuilder and developer who has been recognized as America's Most Trustedâ„¢ Home Builder for five years in a row. Based in Scottsdale, Arizona we operate under two well-established brands, Taylor Morrison and Darling Homes. We create homes and communities that inspire, delight and enhance the quality of life for our customers. We serve a wide array of consumer cohorts from coast to coast, with a focus on first-time, move-up, luxury, and 55-plus. In Texas, Darling Homes builds communities with a focus on individuality and custo... view company details
CTD Holdings, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. CTD Holdings, Inc. was founded in 1990 and is based in Gainesville, Florida. view company details
Camp For All is a unique, barrier-free camp working in partnership with other not-for-profits to enrich the lives of children and adults with challenging illnesses or special needs and their families throughout the year. Camp For All works with 64 different not-for-profits to provide the camping and recreation services to our campers. Our partners bring the campers, counselors and medical staff. We provide the barrier-free site, specialized food service, and trained staff to lead various programs. view company details
Municipal Government of the City of Stevens Point, Wisconsin. Departments include Airport, Assessor, Clerk, Community & Economic Development, Comptroller/Treasurer, EMS/Fire, Forestry, Housing, Parks, Personnel, Police, Public Works, Transit, and Water/Sewerage/Stormewater. Lead by a Mayor and 11-person Common Council. Approximately 16 square miles. Population 26,717. Neighboring communities include the villages of Park Ridge, Plover, and Whiting, and the towns of Hull and Plover. view company details
Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia disease. The company's lead product candidate is DOPTELET that is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo a procedure. It also develops DOPTELET for the treatment of chronic immune thrombocytopenia and chemotherapy-induced thrombocytopenia. Dova Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Durham, North Carolina. view company details
Direct Mail Solutions is a full-service direct mail and fulfillment company located in Richmond, Virginia. Since opening in 1997, DMS has endeavored to provide not only the highest level of data and production services in the industry, but also to assist our partners in maximizing impact while minimizing cost and lead time necessary for their mailings. view company details
Gold Resource Corporation explores for, develops, produces, and sells gold and silver in Mexico and the United States. It also explores for copper, lead, and zinc. The company's flagship property is the Aguila project comprising 18 mining concessions aggregating approximately 25,264 hectares located in the State of Oaxaca, Mexico. Gold Resource Corporation was founded in 1998 and is headquartered in Colorado Springs, Colorado. view company details
Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is diazoxide choline controlled-release, a tablet that is in Phase III clinical trial for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California. view company details
A great school is both an institution of learning and a playground of discovery. We are The Meadowbrook School of Weston, a co-educational independent day school for students in grades Junior Kindergarten through Eight. By fostering in children the sustainable joy of seeking knowledge, facing challenge and pushing limits, we inspire children to live with purpose, learn with passion and lead by practice. view company details
Truckee Meadows Community College provides students choices: over 50 programs of study that lead to more than 160 degree, certificate and other completion options, university transfer, convenience, flexible schedules and affordability. Visit our virtual campus tour to see our five beautiful sites and learn more about TMCC. Go to tour.tmcc.edu to get started. view company details
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its Adhesive Dermally-Applied Microarray technology. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. view company details
Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of transformative central nervous system disorders in the United States. Its lead product candidate is the Fintepla/ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in Emeryville, California. view company details
Coeur Mining, Inc. explores for, develops, and produces gold, silver, zinc, and lead properties. It holds interests in the Palmarejo gold and silver complex located in Mexico; the Rochester silver and gold mine situated in Nevada; the Kensington gold mine located in Alaska; the Wharf gold mine situated in South Dakota; and the Silvertip silver-zinc-lead mine located in Canada. The company also owns interests in the Sterling gold project and the Crown Block of deposits located in the Walker Lane trend in Nevada; and the La Preciosa silver-gold exploration project located in the State of Durango... view company details
Founded in 1985 as a developer of innovative and exciting retail centers, Anchor Health Properties is a national firm that has been devoted exclusively to the development of medical facilities. Our development process incorporates many of the principles basic to the creation of a successful retail center, and our strategic approach to navigating extremely competitive healthcare markets evolved from our days in retail development. As the emphasis of healthcare delivery has shifted to the outpatient setting, it has become more consumer oriented. Location, access, visibility and customer service ... view company details
BroadVision, Inc. develops, markets, and supports enterprise portal applications that enable companies to unify their e-business infrastructure and conduct interactions and transactions with employees, partners, and customers through a personalized self-service model. The company offers business agility suite, a portal that provides personalized views of information and processes; commerce agility suite, an e-commerce system for transacting business on the Web; Clearvale, an enterprise social network solution; Clear, a human resources management system; QuickSilver, a publishing system for lar... view company details
j2 Global, Inc., together with its subsidiaries, provides Internet services worldwide. It operates through three segments: Fax and Email Marketing; Voice, Backup, and Security; and Digital Media. The company offers cloud services to sole proprietors, small to medium-sized businesses and enterprises, and government organizations. Its services include online fax services under the eFax, sFax, MyFax, eFax Plus, eFax Pro, eFax Secure, eFax Corporate, and eFax Developer brands; on-demand voice, cloud phone, and unified communications services under the eVoice, Line2, and Onebox names; online backup... view company details
Socket Mobile, Inc. produces data capture products for mobile applications used in business mobility markets in the United States, Europe, Asia, and internationally. The company's products are incorporated into mobile applications used in point of sale, enterprise mobility, asset tracking, manufacturing process and quality control, transportation and logistics, event management, medical, and education. It provides cordless data capture devices that connect over Bluetooth and work with applications running on smartphones, mobile computers, and tablets; and software developer kits to application... view company details
Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, Iomab-B that is in a pivotal Phase III clinical trial as an induction and conditioning agent in patients over the age of 55 with relapsed or refractory acute myeloid leukemia prior to receiving a bone marrow transplant, also known as a hematopoietic stem cell transplant. The company is also developing Actimab-A, its lead alpha-particle drug cand... view company details
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of oncology drug candidates. Its lead drug candidate is Annamycin that is in Phase I/II clinical trials for the treatment of relapsed or refractory acute myeloid leukemia (AML) in the United States and Poland. The company's flagship immune/transcription modulator is WP1066, a STAT3 inhibitor, which is in Phase I clinical trial for the treatment of brain tumor, as well as to treat pancreatic cancer, AML, and glioblastoma. It also develops WP1220, an analog of WP1066 for the topical treatment of cutaneou... view company details
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta, which is in Phase II clinical trials to treat patients with non-alcoholic fatty liver disease and elevated low-density lipoprotein cholesterol. The company's lead drug candidate also includes VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical tria... view company details